Loading...
Symbols:
Loading...
Symbols:
Earnings Preview: MedcoHealth Solutions
February 15, 2008
| about stocks:
MHS
MedcoHealth Solutions (MHS) is
expected to report Q4 earnings with a conference call scheduled Tuesday, February 19 at
8:30 a.m. ET.
Analysts are looking for a profit of 41c on revenue of $11.47B. The
consensus range is 39c to 47c for EPS, and revenue of $10.88B to $12.01B,
according to First Call. As a prescription benefits manager, PBM, MedcoHealth
profits when blockbuster drugs go generic. When Wyeth (WYE) announced the launch
of a generic version of Protonix, MedcoHealth shares jumped.
Guidance
Analysts are looking for a profit of 41c on revenue of $11.47B. The
consensus range is 39c to 47c for EPS, and revenue of $10.88B to $12.01B,
according to First Call. As a prescription benefits manager, PBM, MedcoHealth
profits when blockbuster drugs go generic. When Wyeth (WYE) announced the launch
of a generic version of Protonix, MedcoHealth shares jumped.
Analyst Views
Morgan Stanley sees slowing earnings growth from retirees and believes UnitedHealth (UNH) could take business in house. UBS downgraded the stock to Neutral from Buy citing a slowing generic pipeline and limited earnings upside. Banc of America reiterated its Buy rating saying the company is poised to report strong results for this quarter.
Related Articles
|
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
Trading Center
- Free E-Newsletters
- About Seeking Alpha
- About Us
- Contact Us
- What's New
- Readers Feedback
- Advertise With Us
- Contributors
- Contribute an Article
- Feature Your Book
- Our Contributors
- Anonymous Contributions
- Dispute an Article?
- Legal
- Terms of Use
- Privacy
- Copyright